XML 75 R56.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Stock-based payment awards  
Schedule of stock-based compensation expense

Year Ended December 31, 

(in thousands)

2024

    

2023

    

2022

Equity award expense

$

14,646

$

12,998

$

11,928

Liability award expense

 

18,393

 

7,910

 

2,569

Total stock-based compensation expense

$

33,039

$

20,908

$

14,497

Schedule of valuation assumptions

Year Ended December 31, 

2024

2023

2022

Remaining performance period as of grant date (in years)

    

2.9

    

2.9

    

2.9

    

Risk-free interest rate used

 

4.1

%  

3.9

%  

1.4

%  

Grant-date fair value

$

23.67

$

15.68

$

11.96

Restricted stock and performance-based restricted stock units  
Stock-based payment awards  
Schedule of restricted stock activity

Weighted

Average

Grant Date

Fair Value

(in thousands, except per share amounts)

    

Shares

    

Per Share

Non-vested restricted stock and performance-based restricted stock units, December 31, 2023

 

2,625

$

10.19

Granted

 

864

 

17.44

Adjustment for performance

13

14.30

Vested

 

(1,188)

 

10.22

Canceled

 

(38)

 

12.08

Non-vested restricted stock and performance-based restricted stock units, December 31, 2024

 

2,276

$

12.81

Cash-settled performance units  
Stock-based payment awards  
Schedule of restricted stock activity

Weighted

Average

Grant Date

Fair Value

(in thousands, except per share amounts)

    

Shares

    

Per Share

Non-vested cash-settled performance units, December 31, 2023

 

548

$

9.37

Granted

 

134

 

16.00

Adjustment for performance

92

10.70

Vested

 

(235)

 

10.70

Canceled

 

 

Non-vested cash-settled performance units, December 31, 2024

 

539

$

10.67